Open Access Open Access  Restricted Access Subscription or Fee Access

Prevalence of Oral Mucositis among Cancer Patient’s Undergoing Chemotherapy

Kripa Angeline A

Abstract


Background: India has one of the highest incidences of oral cancer in the world. The burden of oral cancer is distributed unequally between developed and developing countries. Cancer causes about 13% of all human deaths in 2007. Oral cancer ranks number one among men and number three among women. Mucositis is considered as one of the most common oral problems associated with cancer. Around 40%–70% of cancer patients undergoing high dose of chemotherapy and radiotherapy develops mucositis, which manifests itself as intense erythema in the treated areas, and patients suffer from difficulties with swallowing. Developing on the severity, oral mucositis is classified as tolerable (grade 1 and 2 mucositis) and intolerable mucositis (grade 3 or 4). In severe conditions, mucositis also contributes to local and systemic infections.Aim: The main aim of this study was to know the prevalence of oral mucositis among patients with cancer. Materials and Methods: Quantitative research approach was used for this study. Sixty samples including 40 male and female patients in Cancer Trust Hospital, Puducherry, were selected by simple random sampling technique. The data collection was done by using WHO Oral Mucositis Assessment Scale. The data were analyzed by using descriptive statistics. Result: The study showed that, out of 40 patients, 18 (45%) of them have grade 1 level of oral mucositis, 15 (37.5%) of them have grade 2 level of oral mucositis, and 7 (17.5%) of them have grade 2 level of oral mucositis. Conclusion: The main study was to assess the prevalence of oral mucositis among patients with cancer in Cancer Trust Hospital at Puducherry. This study revealed that the prevalence of oral mucositis is high among patients with cancer.

Background: India has one of the highest incidences of oral cancer in the world. The burden of oral cancer is distributed unequally between developed and developing countries. Cancer causes about 13% of all human deaths in 20071.Oral cancer ranks number one among men and number three among women. Mucositis is considered as one of the most common oral problems associated with cancer.2 Around 40%– - 70% of cancer patients undergoing high dose of chemotherapy and radiotherapy develops mucositis, which manifests itself as intense erythema in the treated areas, and patients suffer from difficulties with swallowing. Developing on the severity, oral mucositis is classified as tolerable(grade 1 and 2 mucositis) and intolerable mucositis(grade3 or 4). In severe conditions, mucositis also contributes to local and& systemic infections.3Aim:The main aim of the currentthis study was to know the prevalence of oral mucositis among patients with cancer.Materials and Methods: Quantitative research approach was used for this study. Sixty samples including 40 male and female patients in Cancer Trust Hospital, Puducherry, were selected by simple random sampling technique. The data collection was done by using WHO Oral Mucositis Assessment Scale. The data were analyzed by using descriptive statistics.Result: The study showed that, the level of oral mucositis out of 40 patients, 18 (45%)of them have grade 1 level of oral mucositis, 15(37.5%) of them have grade 2 level of oral mucositis, and 7 (17.5%) of them have grade 2 level of oral mucositis.Conclusion: The main study was to assess the prevalence of oral mucositis among patients with cancer in Cancer Trust Hospital at Puducherry. This study revealed that the prevalence of oral mucositis is high among patients with cancer.

 


Full Text:

PDF

References


Gandhi K, Datta G, Ahuja S, Saxena T, G Datta A. Prevalence of oral complications occurring in a population of pediatric cancer patients receiving chemotherapy. Int J Clin Pediatr Dent. 2017; 10(2): 166–171p. Doi:10.5005/iD-iournals-10005-1428.

Curra M, Soares Junior LAV, Martins MD, Santos PSDS. Chemotherapy protocols and incidence of oral mucositis. An integrative review. Einstein. 2018; 16(1). Doi:10.1590/S1679-45082018RW4007.

Rao S, Hegde SK, Rao P, Dinkar C, Thilakchand KR, George T, Baliga-Rao MP, Palatty PL, Baliga MS. Honey mitigates radiation-induced oral mucositis in head and neck cancer patients without affecting the tumor response. Foods. 2017; 6(9). Doi:10.3390/foods6090077.

Naidu MU, Ramana GV, Rani PL, Mohan IK, Suman A, Roy P. Chemotherapy-induced and/or radiation therapy-induced oral mucositis complicating the treatment of cancer. Neoplasia. 2004; 6: 423–431p.

Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiate Oncol Biol Phys. 2007; 68: 1110–1120p.

Barasch A, Epstein JB. Management of cancer therapy-induced oral mucositis. Dermatol Ther. 2011; 24: 424–431p.

Rajesh VL, Stephen TS, Douglas EP. Management of oral mucositis in patients with cancer. J Dent Clin N Am. 2008; 52: 61p.

Brown CG, Wingard J. Clinical consequences oral mucositis. Semi Oncol Nurse. 2004; 20: 16–21p.


Refbacks

  • There are currently no refbacks.